A Facile & Scalable in Production Non-Viral Gene Engineered Mesenchymal Stem Cells for Effective Suppression of Temozolomide-Resistant (TMZR) Glioblastoma Growth April 20, 2021 Bioprocessing, Cancer, Gene Editing View this publication by clicking here.